PHAR Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower OSRH Q4 2025 Earnings EPS Miss of 569 Triggers Stock Decline ENVA Q1 2026 Earnings EPS Beats Estimates Stock Rises 139 Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings Miss on EPS as ClinicalStage Biotech Continues Development FRHC Q1 2026 Earnings Robust EPS of 125 Drives Stock Higher COCP Q1 2026 Earnings WiderThanExpected Loss Weighs on EarlyStage Biotech